Galectin-3 in preneoplastic lesions of glioma

Journal of Neuro-Oncology

Volumn 111, Issue 2, 2013, Pages 123-132

  Binh, Nguyen Huy ^a   Satoh, Kunio ^a   Kobayashi, Kazuhiro ^a   Takamatsu, Manabu ^a   Hatano, Yuichiro ^a   Hirata, Akihiro ^a   Tomita, Hiroyuki ^a   Kuno, Toshiya ^a   Hara, Akira ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

ENP; Galectin 3; Glioma; Microtumor

Indexed keywords

ALLOGRAFT INFLAMMATORY FACTOR 1; BIOLOGICAL MARKER; EOSIN; ETHYLNITROSOUREA; GALECTIN 3; GLIAL FIBRILLARY ACIDIC PROTEIN; HEMATOXYLIN; ACTIN BINDING PROTEIN; AIF1 PROTEIN, RAT; ALKYLATING AGENT; CALCIUM BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CANCER; CANCER GROWTH; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; GLIOMA; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MACROPHAGE; MICROGLIA; NONHUMAN; OLIGODENDROGLIA; PRECANCER; PROTEIN EXPRESSION; RAT; ANIMAL; BRAIN TUMOR; CELL PROLIFERATION; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; HUMAN; METABOLISM; WISTAR RAT;

ALKYLATING AGENTS; ANIMALS; BRAIN NEOPLASMS; CALCIUM-BINDING PROTEINS; CELL PROLIFERATION; ETHYLNITROSOUREA; FEMALE; GALECTIN 3; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOMA; HUMANS; MICROFILAMENT PROTEINS; PRECANCEROUS CONDITIONS; RATS; RATS, WISTAR;

MLCS; MLOWN;

EID: 84879297770     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-012-1005-2     Document Type: Article

References (24)

1. Adey WR, Byus CV, Cain CD, Higgins RJ, Jones RA, Kean CJ, Kuster N, MacMurray A, Stagg RB, Zimmerman G (2000) Spontaneous and nitrosourea-induced primary tumors of the central nervous system in Fischer 344 rats exposed to frequency-modulated microwave fields. Cancer Res 60:1857-1863
2. Bresalier RS, Yan PS, Byrd JC, Lotan R, Raz A (1997) Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system. Cancer 80:776-787
3. Dagher SF, Wang JL, Patterson RJ (1995) Identification of galectin-3 as a factor in pre-mRNA splicing. Proc Natl Acad Sci 92:1213-1217
4. Deininger MH, Trautmann K, Meyermann R, Schluesener HJ (2002) Galectin-3 labeling correlates positively in tumor cells and negatively in endothelial cells with malignancy and poor prognosis in oligodendroglioma patients. Anticancer Res 22:1585-1592
5. Fukumori T, Kanayama HO, Raz A (2007) The role of galectin-3 in cancer drug resistance. Drug Resist Update 10:101-108
6. Fukushi J, Makagiansar IT, Stallcup WB (2004) NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha 3 beta 1 integrin. Mol Biol Cell 15:3580-3590
7. Gordower L, Decaestecker C, Kacem Y, Lemmers A, Gusman J, Burchert M (1999) Galectin-3 and galectin-3-binding site expression in human adult astrocytic tumours and related angiogenesis. Neuropathol Appl Neurobiol 25:319-330
8. Hara A, Yamada H, Sakai N, Hirayama H, Tanaka T, Mori H (1990) Immunohistochemical demonstration of the placental form of glutathione S-transferase, a detoxifying enzyme in human gliomas. Cancer 66:2563-2568
9. Hara A (1991) Placental form of glutathione S-tranferase a detoxifying enzyme in gliomas. Acta Sch Med Univ Gifu 39:587-597
10. Koestner A, Swenberg JA, Wechsler W (1971) Transplacental production with ethylnitrosourea of neoplasm of the nervous system in Spraqua-Dawley rat. Am J Pathol 63:37-56
11. Kuwabara I, Liu FT (1996) Galectin-3 promotes adhesion of human neutrophils to laminin. J Immunol 156:3939-3944
12. Le Mercier M, Fortin S, Mathieu V, Kiss R, Lefranc F (2009) Galectins and gliomas. Brain Pathol 20:17-27
13. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2007) WHO classification of tumours of the central nervous system. International Agency for Research on Cancer (IARC), Lyon
14. Oberto G, Rolfo K, Yu P, Carbonatto M, Peano S, Kuster N, Ebert S, Tofani S (2007) Carcinogenicity study of 217 Hz pulsed 900 MHz electromagnetic fields in Pim1 transgenic mice. Radiat Res 168:316-326
15. Ohgaki H, Kleihues P (2005) Epidemiology and etiology of gliomas. Acta Neuropathol 109:93-108
16. Preusser M, de Ribaupierre S, Wöhrer A, Erridge SC, Hegi M, Weller M, Stupp R (2011) Current concepts and management of glioblastoma. Ann Neurol 70:9-21
17. Reifenberger G, Bilzer T, Seitz RJ, Wechsler W (1989) Expression of vimentin and glial fibrillary acidic protein in ethylnitrosourea-induced rat gliomas and glioma cell lines. Acta Neuropathol 78:270-282
18. Satoh K, Niwa M, Goda W, Binh NH, Nakashima M, Takamatsu M, Hara A (2011) Galectin-3 expression in delayed neuronal death of hippocampal CA1 following transient forebrain ischemia, and its inhibition by hypothermia. Brain Res 1382:266-274
19. Strik HM, Deininger MH, Frank B, Schluesener HJ, Meyermann R (2001) Galectin-3: cellular distribution and correlation with WHO-grade in human gliomas. J Neurooncol 53:13-20
20. Vladimirova V, Waha A, Lückerath K, Pesheva P, Probstmeier R (2008) Runx2 is expressed in human glioma cells and mediates the expression of galectin-3. J Neurosci Res 86:2450-2461
21. Wei J, Barr J, Kong LY, Wang Y, Wu A, Sharma AK, Gumin J, Henry V, Colman H, Sawaya R, Lang FF, Heimberger AB (2010) Glioma-associated cancer-initiating cells induce immunosuppression. Clin Cancer Res 16:461-473
22. Yang RY, Hsu DK, Liu FT (1996) Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci USA 93:6737-6742
23. Zeng Y, Danielson KG, Albert TJ, Shapiro IM, Risbud MV (2007) HIF-1 alpha is a regulator of galectin-3 expression in the intervertebral disc. J Bone Miner Res 22:1851-1861
24. Zook BC, Simmens SJ, Jones RV (2000) Evaluation of ENU-induced gliomas in rats: nomenclature, immunochemistry, and malignancy. Toxicol Pathol 28:193-201